{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:30:35Z","timestamp":1770993035044,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Lesch-Nyhan Syndrome Children\u2019s Research Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.neulet.2017.02.016","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T15:40:47Z","timestamp":1486741247000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease"],"prefix":"10.1016","volume":"643","author":[{"given":"Khue Vu","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"Nyhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2017.02.016_bib0005","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/brain\/awt202","article-title":"for the Lesch-Nyhan disease international study group. Genotype-phenotypecorrelations in neurogenetics: lesch-Nyhan disease as a model disorder","volume":"137","author":"Fu","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2017.02.016_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.24191","article-title":"Loss of dopamine phenotype amongmidbrain neurons in Lesch-Nyhan disease","volume":"76","author":"Gottle","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.02.016_bib0015","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/hmg\/ddp164","article-title":"Hypoxanthine-guanine phosphoribosyltransferaseregulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis","volume":"18","author":"Ceballos-Picot","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2017.02.016_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(01)02909-2","article-title":"Abnormal development of hypoxanthineguanine phosphoribosyltransferase-deficient CNS neuroblastoma","volume":"918","author":"Connolly","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2017.02.016_bib0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0306-4522(00)00149-4","article-title":"Abnormalities in cellularadhesion of neuroblastoma and fibroblast models of Lesch-Nyhan syndrome","volume":"98","author":"Stacey","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2017.02.016_bib0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/archneur.55.4.547","article-title":"Craniocerebral magnetic resonance imaging measurement and findings in Lesch-Nyhan syndrome","volume":"55","author":"Harris","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2017.02.016_bib0035","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1474-4422(13)70238-2","article-title":"Regional brain volume abnormalities in Lesch-Nyhan disease and itsvariants: a cross-sectional study","volume":"12","author":"Schretlen","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2017.02.016_bib0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1212\/WNL.0000000000001128","article-title":"Brain white matter volume abnormalities in Lesch-Nyhandisease and its varians","volume":"84","author":"Schretle","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.02.016_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2015.01.042","article-title":"Alzheimer\u2019s disease shares gene expressionaberrations with purinergic dysregulation of HPRT deficiency (Lesch- Nyhan disease)","volume":"590","author":"Kang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2017.02.016_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","article-title":"Roles of amyloid precursorprotein and its fragments in regulating neural activity, plasticity and memory","volume":"70","author":"Turner","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neulet.2017.02.016_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-1-5","article-title":"The amyloid precursor protein: beyond amyloid","volume":"1","author":"Zheng","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2017.02.016_bib0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2014.03.062","article-title":"Epigenetic regulation in amyloid precursor protein and the Lesch- Nyhan syndrome","volume":"446","author":"Nguyen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2017.02.016_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/bmc-2014-0041","article-title":"The human \u03b2-amyloid precursor protein: biomolecular andepigenetic aspects","volume":"6","author":"Nguyen","year":"2015","journal-title":"BioMol. Concepts"},{"key":"10.1016\/j.neulet.2017.02.016_bib0070","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/15257770.2015.1014492","article-title":"Lesch-Nyhan syndrome in a family with a deletionfollowed by an insertion within the HPRT1 gene","volume":"34","author":"Nguyen","year":"2015","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.neulet.2017.02.016_bib0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1383-5742(00)00052-1","article-title":"The spectrumof inherited mutations causing HPRT deficiency: 75 new cases and a review of196 previously reported cases","volume":"463","author":"Jinnah","year":"2000","journal-title":"Mut. Res."},{"key":"10.1016\/j.neulet.2017.02.016_bib0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ymgme.2012.06.003","article-title":"Lesch-Nyhan syndrome: mRNA expression of HPRT in patients with enzyme proven deficiency of HPRT and normal HPRT coding region of the DNA","volume":"106","author":"Nguyen","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neulet.2017.02.016_bib0085","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/15257770.2012.714028","article-title":"Lesch-Nyhan variant syndrome: real-time RT-PCR for mRNA quantification in variable presentation in three affected family members","volume":"31","author":"Nguyen","year":"2012","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.neulet.2017.02.016_bib0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/00032710600964791","article-title":"Utilization of nucleotide probes in ELISA procedure for the quantitative determination of baculovirus titer","volume":"40","author":"Nguyen","year":"2007","journal-title":"Anal. Lett."},{"key":"10.1016\/j.neulet.2017.02.016_bib0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1021\/ac3033239","article-title":"Quantification of amyloid precursor proteinisoforms using quantification concatamer internal standard","volume":"85","author":"Chen","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neulet.2017.02.016_bib0100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymgme.2013.08.016","article-title":"Phenotype variation among seven membersof one family with deficiency of hypoxanthine-guanine phosphoribosyltransferase","volume":"110","author":"Ceballos-Picot","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neulet.2017.02.016_bib0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000073735","article-title":"The ubiquitous nature of epistasis in determining susceptibility to common human diseases","volume":"56","author":"Moore","year":"2003","journal-title":"Hum. Hered."},{"key":"10.1016\/j.neulet.2017.02.016_bib0110","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/j.1460-2075.1988.tb03136.x","article-title":"Thepromoter of Alzheimer\u2019s disease amyloid A4 precursor gene","volume":"7","author":"Sabaum","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.neulet.2017.02.016_bib0115","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.108712","article-title":"Amyloid precursor protein and neural development","volume":"141","author":"Nicolas","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.neulet.2017.02.016_bib0120","doi-asserted-by":"crossref","first-page":"e20405","DOI":"10.1371\/journal.pone.0020405","article-title":"Increased secreted amyloid precursorprotein-\u03b1 (sAPP\u03b1) in severe autism: proposal of a specific, anabolic pathway and putative biomarker","volume":"6","author":"Ray","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2017.02.016_bib0125","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0b013e3182166dc7","article-title":"Autism, Alzheimer\u2019sdisease, and fragile X, APP, FMRP, and mGluR5 are molecular links","volume":"76","author":"Sokol","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.02.016_bib0130","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1093\/hmg\/dds215","article-title":"Amyloid precursor protein (APP) contributes topathology in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"21","author":"Bryson","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2017.02.016_bib0135","first-page":"123","article-title":"A\u03b2-independent processes-rethinking preclinical AD","volume":"9","author":"Chetelat","year":"2013","journal-title":"Nat. Rev."},{"key":"10.1016\/j.neulet.2017.02.016_bib0140","first-page":"77","article-title":"Antisense therapy: a magic bullet for the treatment of variousdiseases: present and future prospects","volume":"3","author":"Saonere","year":"2011","journal-title":"J. Med. Genet. Genom."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017301222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017301222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:14:03Z","timestamp":1568805243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394017301222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":28,"alternative-id":["S0304394017301222"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2017.02.016","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2017.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}